In Vitro Interactions of Approved and Novel Drugs against Paecilomyces spp.

AUTOR(ES)

Ortoneda, Montserrat

FONTE

American Society for Microbiology

RESUMO

We have evaluated the in vitro activity of 15 combinations of antifungal drugs (amphotericin B, itraconazole, voriconazole, albaconazole, ravuconazole, terbinafine, and micafungin) against four isolates of Paecilomyces variotii and three of P. lilacinus. The interaction of terbinafine with the four azoles was synergistic for 53% of the combinations, while the interactions of both amphotericin B and micafungin with the rest of antifungal agents were mainly indifferent.

Documentos Relacionados

• In Vitro Activities of Four Novel Triazoles against Scedosporium spp.
• In Vitro Activities of Ravuconazole and Voriconazole Compared with Those of Four Approved Systemic Antifungal Agents against 6,970 Clinical Isolates of Candida spp.
• In vitro activity of cefbuperazone against Bacteroides spp.
• In Vitro and In Vivo Activities of Sitafloxacin against Chlamydia spp.
• In vitro activities of new macrolides and rifapentine against Brucella spp.